Publications by authors named "H Lerat"

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The AKT pathway is often activated in HCC cases, and a longer exposure to tyrosine kinase inhibitors such as sorafenib may lead to over-activation of the AKT pathway, leading to HCC resistance. Here, we studied the efficacy of a new generation of allosteric AKT inhibitor, vevorisertib, alone or in combination with sorafenib.

View Article and Find Full Text PDF

Obstructive sleep apnea (OSA) syndrome is characterized by chronic intermittent hypoxia and is associated with an increased risk of all-cause mortality, including cancer mortality. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, characterized by increasing incidence and high mortality. However, the link between HCC and OSA-related chronic intermittent hypoxia remains unclear.

View Article and Find Full Text PDF

Mice respond to a cage change (CC) with altered activity, disrupted sleep and increased anxiety. A bi-weekly cage change is, therefore, preferred over a shorter CC interval and is currently the prevailing routine for Individually ventilated cages (IVCs). However, the build-up of ammonia (NH3) during this period is a potential threat to the animal health and the literature holds conflicting reports leaving this issue unresolved.

View Article and Find Full Text PDF
Article Synopsis
  • - Hepatocellular carcinoma (HCC) is largely linked to liver diseases such as fibrosis and cirrhosis, and the immune system plays a key role in the disease's progression.
  • - A study used Fischer 344 male rats, injecting them with DEN over 14 weeks to model HCC and assess changes in the liver's inflammatory environment and tissue structure.
  • - Findings revealed that DEN-induced tumors in rats exhibit similar molecular features to human HCC, providing valuable insights for future research and potential preclinical testing.
View Article and Find Full Text PDF

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, characterized by hepatic steatosis without any alcohol abuse. As the prevalence of NAFLD is rapidly increasing worldwide, important research activity is being dedicated to deciphering the underlying molecular mechanisms in order to define new therapeutic targets. To investigate these pathways and validate preclinical study, reliable, simple and reproducible tools are needed.

View Article and Find Full Text PDF